首页> 外文OA文献 >Large screen approaches to identify novel malaria vaccine candidates
【2h】

Large screen approaches to identify novel malaria vaccine candidates

机译:大屏幕方法识别新型疟疾疫苗候选者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Until recently, malaria vaccine development efforts have focused almost exclusively on a handful of well characterized Plasmodium falciparum antigens. Despite dedicated work by many researchers on different continents spanning more than half a century, a successful malaria vaccine remains elusive. Sequencing of the P. falciparum genome has revealed more than five thousand genes, providing the foundation for systematic approaches to discover candidate vaccine antigens. We are taking advantage of this wealth of information to discover new antigens that may be more effective vaccine targets. Herein, we describe different approaches to large-scale screening of the P. falciparum genome to identify targets of either antibody responses or T cell responses using human specimens collected in Controlled Human Malaria Infections (CHMI) or under conditions of natural exposure in the field. These genome, proteome and transcriptome based approaches offer enormous potential for the development of an efficacious malaria vaccine.
机译:直到最近,疟疾疫苗的开发工作几乎都集中在少数特征明确的恶性疟原虫抗原上。尽管跨半个世纪以来,许多研究人员在不同大陆上进行了专门研究,但成功的疟疾疫苗仍然难以捉摸。恶性疟原虫基因组的测序已揭示了五千多个基因,为发现候选疫苗抗原的系统方法奠定了基础。我们正在利用这些丰富的信息来发现可能是更有效的疫苗靶标的新抗原。在此,我们描述了使用恶性疟原虫基因组进行大规模筛选的不同方法,以使用在受控人类疟疾感染(CHMI)中或在自然暴露条件下收集的人类标本鉴定抗体应答或T细胞应答的靶标。这些基于基因组,蛋白质组和转录组的方法为开发有效的疟疾疫苗提供了巨大的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号